recombinant vascular endothelial growth factor -Fc fusion protein (Taitai Yinkang Biopharmaceutical)

N/A

Report date: 2025/01/26 15:17:20

Base Information

Drug Namerecombinant vascular endothelial growth factor -Fc fusion protein (Taitai Yinkang Biopharmaceutical)
Drug Alias NameIBI-304
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionVascular endothelial growth factor receptor modulators
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesTiantai Yinkang Biological Medicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTiantai Yinkang Biological Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionWet age-related macular degeneration +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A